Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75% as a ...
SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...
A bill aimed at imposing a 10% tax on vapor products and requiring FDA approval before vape products are sold passed a key ...
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as ...
The statement said the issue will be discussed at an upcoming meeting of CDC’s expert vaccine panel, ACIP. It was scheduled ...
Consumers who have this product should discontinue use immediately and return it to the place of purchase or discard it,” the ...
In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...
Q4 2024 Earnings Call Transcript February 25, 2025 Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...
Discover how next-generation kinase inhibitors are transforming clinical therapy byovercoming resistance and enhancing ...
The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable ...
Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would ...
Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results